Prader-Willi Syndrome Clinical Trial
Official title:
Optimizing the Social Engagement System in Prader-Willi Syndrome: Insights From the Polyvagal Theory
Verified date | March 2023 |
Source | Indiana University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The Polyvagal Theory focuses on how function and structure changed in the vertebrate autonomic nervous system during evolution. The theory is named for the vagus, a major cranial nerve that regulates bodily state. As a function of evolution, humans and other mammals have a "new" vagal pathway that links the regulation of bodily state to the control of the muscles of the face and head including the middle ear muscles. These pathways regulating body state, facial gesture, listening (i.e., middle ear muscles), and vocal communication collectively function as a Social Engagement System (SES). Because the Social Engagement System is an integrated system, interventions influencing one component of this system (e.g., middle ear muscles) may impact on the other components. Individuals with Prader-Willi Syndrome (PWS) exhibit many behaviors that are consistent with a compromised Social Engagement System. Atypical function of the Social Engagement System results in problems associated with state regulation (e.g., impulsivity, tantrums, and difficulty with change in routine), ingestion (e.g., difficulties in sucking at birth, hyperphagia), coordination of suck/swallow/breathe, intonation of vocalizations, auditory processing and hypersensitivity, and socialization. We propose to confirm that several features of the behavioral phenotype of PWS may be explained within the context of a dysfunctional SES (Specific Aim I), which may be partially rehabilitated via an intervention designed as a 'neural exercise' of the SES (Specific Aim II). Specific Aims: Aim I: To demonstrate that children with PWS have atypical regulation of the SES. We hypothesize these effects will be manifested by dampened vagal regulation of the heart (low parasympathetic tone); poor middle ear muscle regulation resulting in auditory hypersensitivities and poor auditory processing; lack of voice intonation (prosody), and difficulties in accurately detecting the emotions of others. Aim II: To demonstrate the effectiveness of the Listening Project Protocol (LPP) in decreasing the atypical features of the SES in adolescents with PWS. We hypothesize that individuals who complete the LPP will have improved vagal regulation of the heart, improved middle ear muscle regulation, increased voice intonation and improved ability to accurately detect the emotions of others.
Status | Terminated |
Enrollment | 5 |
Est. completion date | March 8, 2023 |
Est. primary completion date | March 8, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 13 Years to 25 Years |
Eligibility | Inclusion Criteria: 1. Participants must be current residents at Latham Centers (LC) School in Brewster MA 2. Participants must meet criteria for Prader-Willi Syndrome 3. Participants must be between ages 13 - 25 years 4. Participants must have normal hearing 5. Participants must have normal vision (or corrected vision) Exclusion Criteria: 1. Individuals with current (or a history of) heart disease 2. Individuals who are hearing-impaired 3. Individuals who are being treated for seizure disorder 4. Individuals who do not read/speak English 5. Individuals who are sight-impaired without correction |
Country | Name | City | State |
---|---|---|---|
United States | Latham Centers School | Brewster | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Indiana University | Latham Centers |
United States,
Bal E, Harden E, Lamb D, Van Hecke AV, Denver JW, Porges SW. Emotion recognition in children with autism spectrum disorders: relations to eye gaze and autonomic state. J Autism Dev Disord. 2010 Mar;40(3):358-70. doi: 10.1007/s10803-009-0884-3. — View Citation
Borg E, Counter SA. The middle-ear muscles. Sci Am. 1989 Aug;261(2):74-80. doi: 10.1038/scientificamerican0889-74. No abstract available. — View Citation
Lewis GF, Furman SA, McCool MF, Porges SW. Statistical strategies to quantify respiratory sinus arrhythmia: are commonly used metrics equivalent? Biol Psychol. 2012 Feb;89(2):349-64. doi: 10.1016/j.biopsycho.2011.11.009. Epub 2011 Dec 3. — View Citation
Porges SW, Bazhenova OV, Bal E, Carlson N, Sorokin Y, Heilman KJ, Cook EH, Lewis GF. Reducing auditory hypersensitivities in autistic spectrum disorder: preliminary findings evaluating the listening project protocol. Front Pediatr. 2014 Aug 1;2:80. doi: 10.3389/fped.2014.00080. eCollection 2014. — View Citation
Porges SW, Macellaio M, Stanfill SD, McCue K, Lewis GF, Harden ER, Handelman M, Denver J, Bazhenova OV, Heilman KJ. Respiratory sinus arrhythmia and auditory processing in autism: modifiable deficits of an integrated social engagement system? Int J Psychophysiol. 2013 Jun;88(3):261-70. doi: 10.1016/j.ijpsycho.2012.11.009. Epub 2012 Nov 29. — View Citation
Porges SW. The polyvagal theory: phylogenetic substrates of a social nervous system. Int J Psychophysiol. 2001 Oct;42(2):123-46. doi: 10.1016/s0167-8760(01)00162-3. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Stability of Autonomic regulation | Respiratory sinus arrhythmia (RSA) | Change from 6 months pre-intervention RSA to 1 week pre-intervention | |
Other | Immediate effects of intervention on Autonomic regulation | Respiratory sinus arrhythmia (RSA) | Change from 1 week pre-intervention RSA to 1 week post-intervention | |
Other | Short-term effects of intervention on Autonomic regulation | Respiratory sinus arrhythmia (RSA) | Change from 1 week post-intervention RSA to 1 month post-intervention | |
Other | Stability of Heart period | heart period | Change from 6 months pre-intervention heart period to 1 week pre-intervention | |
Other | Immediate effects of intervention on Heart period | heart period | Change from 1 week pre-intervention heart period to 1 week post-intervention | |
Other | Short-term effects of intervention on Heart period | heart period | Change from 1 week post-intervention heart period to 1 month post-intervention | |
Other | Stability of Auditory processing | Filtered Words subtest of SCAN | Change from 6 months pre-intervention Filtered Words to 1 week pre-intervention | |
Other | Immediate effects of intervention on Auditory processing | Filtered Words subtest of SCAN | Change from 1 week pre-intervention Filtered Words to 1 week post-intervention | |
Other | Short-term effects of intervention on Auditory processing | Filtered Words subtest of SCAN | Change from 1 week post-intervention Filtered Words to 1 month post-intervention | |
Other | Stability of Auditory processing | Competing Words subtest of SCAN | Change from 6 months pre-intervention Competing Words to 1 week pre-intervention | |
Other | Immediate effects of intervention on Auditory processing | Competing Words subtest of SCAN | Change from 1 week pre-intervention Competing Words to 1 week post-intervention | |
Other | Short-term effects of intervention on Auditory processing | Competing Words subtest of SCAN | Change from 1 week post-intervention Competing Words to 1 month post-intervention | |
Other | Stability of Sensory Sensitivities | BBC Sensory Scales (questionnaire) | Change from 6 months pre-intervention BBC Sensory Scales to 1 week pre-intervention | |
Other | Stability of Latency to Affect recognition | Dynamic Affect Recognition Evaluation (DARE) - latency | Change from 6 months pre-intervention DARE latency to 1 week pre-intervention | |
Other | Immediate effects of intervention on Latency to Affect recognition | Dynamic Affect Recognition Evaluation (DARE) - latency | Change from 1 week pre-intervention DARE latency to 1 week post-intervention | |
Other | Short-term effects of intervention on Latency to Affect recognition | Dynamic Affect Recognition Evaluation (DARE) - latency | Change from 1 week post-intervention DARE latency to 1 month post-intervention | |
Other | Stability of Accuracy of Affect recognition | Dynamic Affect Recognition Evaluation (DARE) - accuracy | Change from 6 months pre-intervention DARE accuracy to 1 week pre-intervention | |
Other | Immediate effects of intervention on Accuracy of Affect recognition | Dynamic Affect Recognition Evaluation (DARE) - accuracy | Change from 1 week pre-intervention DARE accuracy to 1 week post-intervention | |
Other | Short-term effects of intervention on Accuracy of Affect recognition | Dynamic Affect Recognition Evaluation (DARE) - accuracy | Change from 1 week post-intervention DARE accuracy to 1 month post-intervention | |
Other | Stability of Prosody | Analyses of vocal recordings | Change from 6 months pre-intervention prosody to 1 week pre-intervention | |
Other | Immediate effects of intervention on Prosody | Analyses of vocal recordings | Change from 1 week pre-intervention prosody to 1 week post-intervention | |
Other | Short-term effects of intervention on Prosody | Analyses of vocal recordings | Change from 1 week post-intervention prosody to 1 month post-intervention | |
Other | Stability of Disruptive behavior | Developmental Behavior Checklist (DBC) (questionnaire) | Change from 6 months pre-intervention DBC to 1 week pre-intervention | |
Other | Immediate effects of intervention on Disruptive behavior | Developmental Behavior Checklist (DBC) (questionnaire) | Change from 1 week pre-intervention DBC to 1 week post-intervention | |
Other | Short-term effects of intervention on Disruptive behavior | Developmental Behavior Checklist (DBC) (questionnaire) | Change from 1 week post-intervention DBC to 1 month post-intervention | |
Other | Stability of Oxytocin | oxytocin levels derived from salivary sample | Change from 6 months pre-intervention oxytocin to 1 week pre-intervention | |
Other | Stability of Vasopressin | vasopressin levels derived from salivary sample | Change from 6 months pre-intervention vasopressin to 1 week pre-intervention | |
Primary | Effect of Intervention on Autonomic regulation | Respiratory sinus arrhythmia (RSA) | Change from 1 week pre-intervention RSA to 1 month post-intervention | |
Secondary | Effect of Intervention on Heart period | heart period | Change from 1 week pre-intervention heart period to 1 month post-intervention | |
Secondary | Effect of Intervention on Auditory processing | Filtered Words subtest of SCAN | Change from 1 week pre-intervention Filtered Words to 1 month post-intervention | |
Secondary | Effect of Intervention on Auditory processing | Competing Words subtest of SCAN | Change from 1 week pre-intervention Competing Words to 1 month post-intervention | |
Secondary | Effect of Intervention on Sensory Sensitivities | BBC Sensory Scales (questionnaire) | Change from 1 week pre-intervention BBC Sensory Scales to 1 month post-intervention | |
Secondary | Effect of Intervention on Latency to Affect recognition | Dynamic Affect Recognition Evaluation (DARE) - latency | Change from 1 week pre-intervention DARE (latency) to 1 month post-intervention | |
Secondary | Effect of Intervention on Accuracy of Affect recognition | Dynamic Affect Recognition Evaluation (DARE) - accuracy | Change from 1 week pre-intervention DARE (accuracy) to 1 month post-intervention | |
Secondary | Effect of Intervention on Prosody | Analyses of vocal recordings | Change from 1 week pre-intervention Prosody to 1 month post-intervention | |
Secondary | Effect of Intervention on Disruptive Behavior | Developmental Behavior Checklist (DBC) (questionnaire) | Change from 1 week pre-intervention DBC to 1 month post-intervention | |
Secondary | Effect of Intervention on Social behavior | Listening Project Parent (LPP) Questionnaire | Change from 1 week post-intervention LPP to 1 month post-intervention | |
Secondary | Effect of Intervention on Oxytocin | oxytocin levels derived from salivary sample | Change from 1 week pre-intervention oxytocin to 1 month post-intervention | |
Secondary | Effect of Intervention on Vasopressin | vasopressin levels derived from salivary sample | Change from 1 week pre-intervention vasopressin to 1 month post-intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05032326 -
Long-term Interventional Follow-up Study of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial
|
Phase 3 | |
Completed |
NCT04526379 -
Study of Emotion and Cognition Abilities of Children With PWS and Proposition of an Innovative Remediation
|
N/A | |
Terminated |
NCT03458416 -
A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Participants With Prader-Willi Syndrome
|
Phase 2 | |
Completed |
NCT03718416 -
Natural History Study of Serious Medical Events in PWS
|
||
Completed |
NCT05322096 -
Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi Syndrome
|
Phase 2 | |
Completed |
NCT02205450 -
Growth Hormone in Children Under 2 Years With Prader-Willi in Hospital of Sabadell
|
||
Terminated |
NCT02179151 -
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
|
Phase 3 | |
Completed |
NCT00375089 -
Characteristics of Prader-Willi Syndrome and Early-onset Morbid Obesity
|
N/A | |
Completed |
NCT00004351 -
Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes
|
N/A | |
Recruiting |
NCT05938543 -
Cerebellar TMS and Satiety in Prader-Willi Syndrome
|
N/A | |
Suspended |
NCT05879614 -
An Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001)
|
Phase 2 | |
Recruiting |
NCT03031626 -
Oxygen Versus Medical Air for Treatment of CSA in Prader Will Syndrome
|
Phase 4 | |
Withdrawn |
NCT04086810 -
An Open-Label Study of DCCR Tablet in Patients With PWS
|
Phase 3 | |
Completed |
NCT02629991 -
Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome
|
Phase 2 | |
Recruiting |
NCT02297022 -
Deep Brain Stimulation for the Treatment of Obesity in Patients With Prader-Willi Syndrome
|
Phase 1 | |
Not yet recruiting |
NCT02263781 -
PREPL in Health and Disease
|
N/A | |
Completed |
NCT00551343 -
Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome
|
N/A | |
Recruiting |
NCT06448871 -
Ultrasound to Assess Sarcopenia in Prader Willi Syndrome
|
||
Enrolling by invitation |
NCT03655223 -
Early Check: Expanded Screening in Newborns
|
||
Recruiting |
NCT05939453 -
Impact of Bright Light Therapy on Prader-Willi Syndrome
|
N/A |